Compare
Moderna vs Regeneron Pharmaceuticals
Moderna (MRNA) and Regeneron Pharmaceuticals (REGN) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.
| Moderna MRNANASDAQ · Biotechnology | Regeneron Pharmaceuticals REGNNASDAQ · Biotechnology | |
|---|---|---|
| Insider records, last 12 months | 251 | 176 |
| Congress trades, last 12 months | 3 | 4 |
| Fund positions reported, last 12 months | 33 | 128 |
| Federal contract awards, last 12 months | 0 | 0 |
| Open-market purchases by insiders since 2006 | 4 | 551 |
| Open-market sales by insiders since 2006 | 2,760 | 3,908 |
| Last open-market purchase by an insider | Mar 4, 2025 | Aug 25, 2017 |
| Next results | Oct 29, 2026 | Oct 30, 2026 |
Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.
Common questions
Which has had more insider buying, Moderna or Regeneron Pharmaceuticals?
Since 2006, Regeneron Pharmaceuticals insiders reported 551 open-market purchases against 4 for Moderna, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.
Do members of Congress trade MRNA or REGN?
In the last 12 months, members of Congress disclosed 3 trades in Moderna (MRNA) and 4 in Regeneron Pharmaceuticals (REGN), each reported as a value range on a periodic transaction report.
When did insiders last buy MRNA and REGN?
Moderna: Mar 4, 2025. Regeneron Pharmaceuticals: Aug 25, 2017. Dates are those of the SEC filings.
See the record behind any of these
Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Moderna pageRegeneron Pharmaceuticals pageRare insider trades this weekAll comparisons
https://oqro.io/compare/mrna-vs-regn